Mebendazole as Adjuvant Treatment for Colon Cancer
ConditionColorectal Cancer
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSherief Abd-Elsalam
About this trial
mebendazole treating colon cancer
Eligibility criteria
Qualifiers
Colorectal cancer stage 4.
Disqualifiers
Agranulocytosis
Pregnancy
Allergy to mebendazole.
Trial design
Treatments tested in this trial
- Folfox with avastin
- Mebendazole
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov